Skip to main content
SpringerLink
Log in

ASO Author Reflections: Multimodality (Hybrid) Management of Thoracic Tumors–Why and How?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) non-small cell lung cancer. Published online February 17, 2023. Accessed April 5, 2023. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

  2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) colon cancer. Published online March 29, 2023. Accessed April 5, 2023. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

  3. Osarogiagbon RU. Making the evidentiary case for universal multidisciplinary thoracic oncologic care. Clin Lung Cancer. 2018;19(4):294–300. https://doi.org/10.1016/j.cllc.2018.05.006.

    Article  PubMed  Google Scholar 

  4. Graur A, Saenger JA, Mercaldo ND, et al. Multimodality management of thoracic tumors: initial experience with a multidisciplinary thoracic ablation conference. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-14910-z.

    Article  PubMed  Google Scholar 

  5. Antonoff MB, Sofocleous CT, Callstrom MR, Nguyen QN. The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases. J Thorac Cardiovasc Surg. 2022;163(2):495–502. https://doi.org/10.1016/j.jtcvs.2021.01.143.

    Article  PubMed  Google Scholar 

Download references

Funding

Dr. Fintelmann reports salary support from the William M. Wood Foundation for related research, speaking and consulting for Boston Scientific, and research support from Pfizer. Dr. Lanuti received honoraria from Iovance Biotherapeutics. The other author has no relevant conflicts of interest to report.

Author information

Authors and Affiliations

  1. Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA

    Alexander Graur Cand. Med. & Florian J. Fintelmann MD

  2. Department of Radiology, Ludwig-Maximilians-University, Munich, Germany

    Alexander Graur Cand. Med.

  3. Department of Surgery, Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA, USA

    Michael Lanuti MD

Authors
  1. Alexander Graur Cand. Med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Lanuti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florian J. Fintelmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian J. Fintelmann MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Graur A, Saenger JA, Mercaldo ND, et al. Multimodality management of thoracic tumors: initial experience with a multidisciplinary thoracic ablation conference. Ann Surg Oncol. (2024). https://doi.org/10.1245/s10434-024-14910-z.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Graur, A., Lanuti, M. & Fintelmann, F.J. ASO Author Reflections: Multimodality (Hybrid) Management of Thoracic Tumors–Why and How?. Ann Surg Oncol 31, 3856–3857 (2024). https://doi.org/10.1245/s10434-024-15003-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-15003-7

Search

Navigation